Terms: = Leukemia AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1
13 results:
1. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
Katoh M
Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
[TBL] [Abstract] [Full Text] [Related]
2. Functional and cancer genomics of ASXL family members.
Katoh M
Br J Cancer; 2013 Jul; 109(2):299-306. PubMed ID: 23736028
[TBL] [Abstract] [Full Text] [Related]
3. Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.
Fabris S; Mosca L; Cutrona G; Lionetti M; Agnelli L; Ciceri G; Barbieri M; Maura F; Matis S; Colombo M; Gentile M; Recchia AG; Anna Pesce E; Di Raimondo F; Musolino C; Gobbi M; Di Renzo N; Mauro FR; Brugiatelli M; Ilariucci F; Lipari MG; Angrilli F; Consoli U; Fragasso A; Molica S; Festini G; Vincelli I; Cortelezzi A; Federico M; Morabito F; Ferrarini M; Neri A
Am J Hematol; 2013 Jan; 88(1):24-31. PubMed ID: 23044996
[TBL] [Abstract] [Full Text] [Related]
4. Cancer in Kashmir, India: burden and pattern of disease.
Rasool MT; Lone MM; Wani ML; Afroz F; Zaffar S; Mohib-ul Haq M
J Cancer Res Ther; 2012; 8(2):243-6. PubMed ID: 22842369
[TBL] [Abstract] [Full Text] [Related]
5. Silicon analogues of the retinoid agonists TTNPB and 3-methyl-TTNPB, disila-TTNPB and disila-3-methyl-TTNPB: chemistry and biology.
Büttner MW; Burschka C; Daiss JO; Ivanova D; Rochel N; Kammerer S; Peluso-Iltis C; Bindler A; Gaudon C; Germain P; Moras D; Gronemeyer H; Tacke R
Chembiochem; 2007 Sep; 8(14):1688-99. PubMed ID: 17768726
[TBL] [Abstract] [Full Text] [Related]
6. Aberrant chromatin remodeling by retinoic acid receptor alpha fusion proteins assessed at the single-cell level.
Qiu J; Huang Y; Chen G; Chen Z; Tweardy DJ; Dong S
Mol Biol Cell; 2007 Oct; 18(10):3941-51. PubMed ID: 17671166
[TBL] [Abstract] [Full Text] [Related]
7. Aberrant association of promyelocytic leukemia protein-retinoic acid receptor-alpha with coactivators contributes to its ability to regulate gene expression.
Reineke EL; Liu H; Lam M; Liu Y; Kao HY
J Biol Chem; 2007 Jun; 282(25):18584-18596. PubMed ID: 17475621
[TBL] [Abstract] [Full Text] [Related]
8. Evolutionary identification of a subtype specific functional site in the ligand binding domain of steroid receptors.
Raviscioni M; He Q; Salicru EM; Smith CL; Lichtarge O
Proteins; 2006 Sep; 64(4):1046-57. PubMed ID: 16835908
[TBL] [Abstract] [Full Text] [Related]
9. RARbeta ligand-binding domain bound to an SRC-1 co-activator peptide: purification, crystallization and preliminary X-ray diffraction analysis.
Kammerer S; Germain P; Flaig R; Peluso-Iltis C; Mitschler A; Rochel N; Gronemeyer H; Moras D
Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):2048-50. PubMed ID: 15502323
[TBL] [Abstract] [Full Text] [Related]
10. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.
Rivera OJ; Song CS; Centonze VE; Lechleiter JD; Chatterjee B; Roy AK
Mol Endocrinol; 2003 Jan; 17(1):128-40. PubMed ID: 12511612
[TBL] [Abstract] [Full Text] [Related]
11. p53 Transcriptional activity is mediated through the src1-interacting domain of CBP/p300.
Livengood JA; Scoggin KE; Van Orden K; McBryant SJ; Edayathumangalam RS; Laybourn PJ; Nyborg JK
J Biol Chem; 2002 Mar; 277(11):9054-61. PubMed ID: 11782467
[TBL] [Abstract] [Full Text] [Related]
12. The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation.
Scoggin KE; Ulloa A; Nyborg JK
Mol Cell Biol; 2001 Aug; 21(16):5520-30. PubMed ID: 11463834
[TBL] [Abstract] [Full Text] [Related]
13. The map of chromosome 20.
Simpson NE
J Med Genet; 1988 Dec; 25(12):794-804. PubMed ID: 3070044
[TBL] [Abstract] [Full Text] [Related]
